International
Ivermectin, a controversial anti-parasitic drug that has been touted by some as a potential Covid-19 treatment, does not help people with mild covid-19 recover faster, according to a new clinical trial. The trial found that the duration of symptoms was not significantly different for patients who received a 5-day course of ivermectin compared with placebo. the authors say the findings do not support the use of ivermectin for the treatment of mild COVID-19, although larger trials may be needed to understand effects on other clinically relevant outcomes.
Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.
Sign In
